Lupin Stock: Risk and Return

Lupin was an innovation-led transnational pharmaceutical company headquartered in Mumbai. It was founded in 1968 by Dr. Desh Bandhu Gupta. The company was created with the vision of fighting life-threatening infectious diseases and manufacturing drugs of the highest social priority. By 2017, it was producing a wide range of quality, affordable generic and branded formulations and active pharmaceutical ingredients (APIs) for the developed and developing markets of the world. Lupin was a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective, and NSAID space and held the global leadership position in the Anti-TB segment. The company’s drugs and products were sold in over 100 countries in the world..